Key result
Distinguishing features between pathologic left ventricular hypertrophy, athlete's heart, and phenocopies like Anderson-Fabry disease and cardiac amyloidosis can resolve diagnostic dilemmas.
This review highlights important distinguishing features to differentiate pathologic left ventricular hypertrophy from physiologic hypertrophy and phenocopies like Anderson-Fabry disease and cardiac amyloidosis.
Pathologic left ventricular hypertrophy due to hypertrophic cardiomyopathy is typically diagnosed based on compatible clinical and imaging findings. In a subset of patients however, the diagnosis is unclear, either due to the finding of concentric hypertrophy raising the possibility of physiologic hypertrophy due to athlete's heart or due to the potential of so-called hypertrophic cardiomyopathy 'phenocopies', which include Anderson-Fabry disease and cardiac amyloidosis. We review each of these diseases, highlighting important distinguishing features, the knowledge of which should permit the resolution of such diagnostic dilemmas.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2014) conducted a review in Left ventricular hypertrophy. Distinguishing features between pathologic left ventricular hypertrophy, athlete's heart, and phenocopies like Anderson-Fabry disease and cardiac amyloidosis can resolve diagnostic dilemmas.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: